Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Philip Rotella"'
Publikováno v:
European Respiratory Review, Vol 21, Iss 126, Pp 355-361 (2012)
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial pneumonia of unknown aetiology. It is a rare disease, and its incidence and prevalence are not clear. Therefore, we sought to review the published evidence on the g
Externí odkaz:
https://doaj.org/article/33718ea66bfa4802aecefc75ac422fe0
Publikováno v:
European Respiratory Review, Vol 21, Iss 126, Pp 355-361 (2012)
Eur Respir Rev
Eur Respir Rev
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial pneumonia of unknown aetiology. It is a rare disease, and its incidence and prevalence are not clear. Therefore, we sought to review the published evidence on the g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::085b9182825734d437d512c38f48af38
Autor:
Ruzan Avetisyan, Natalie Jones, Sheila Crean, Philip Rotella, Matthew W. Reynolds, Sumesh Kachroo, Gary Schneider
Publikováno v:
Pharmacoepidemiology and Drug Safety. 21:248-255
Purpose The Food and Drug Administration's Mini-Sentinel pilot program aims to conduct active surveillance to refine safety signals that emerge for marketed medical products. A key facet of this surveillance is to develop and understand the validity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9590ac1d0dfa370e6ccd51916982aec
https://doi.org/10.1002/pds.2333
https://doi.org/10.1002/pds.2333
Autor:
Ruzan Avetisyan, Gary Schneider, Matthew W. Reynolds, Natalie Jones, Sumesh Kachroo, Philip Rotella
Publikováno v:
Pharmacoepidemiology and Drug Safety. 21:256-260
Purpose The Food and Drug Administration's Mini-Sentinel pilot program initially aimed to conduct active surveillance to refine safety signals that emerge for marketed medical products. A key facet of this surveillance is to develop and understand th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a556bcc73b35465617ae76169dc6f2d
https://doi.org/10.1002/pds.2338
https://doi.org/10.1002/pds.2338
Autor:
Ruzan Avetisyan, Matthew W. Reynolds, Sumesh Kachroo, Natalie Jones, Gary Schneider, Philip Rotella, Sheila Crean
Publikováno v:
Pharmacoepidemiology and Drug Safety. 21:236-239
Purpose The Food and Drug Administration's (FDA) Mini-Sentinel pilot program aims to conduct active surveillance to refine safety signals that emerge for marketed medical products. A key facet of this surveillance is to develop and understand the val
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::273070de59d8f9b065c11dbffc7dd8f5
https://doi.org/10.1002/pds.2331
https://doi.org/10.1002/pds.2331
Autor:
Philip Rotella, Sheila Crean, Natalie Jones, Sumesh Kachroo, Gary Schneider, Ruzan Avetisyan, Matthew W. Reynolds
Publikováno v:
Pharmacoepidemiology and Drug Safety. 21:240-247
Purpose The Food and Drug Administration’s Mini-Sentinel pilot program initially aims to conduct active surveillance to refine safety signals that emerge for marketed medical products. A key facet of this surveillance is to develop and understand t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7def0215fc81f011a7a487c219545bd
https://doi.org/10.1002/pds.2327
https://doi.org/10.1002/pds.2327
Autor:
Philip Rotella, Sumesh Kachroo, Natalie Jones, Gary Schneider, Matthew W. Reynolds, Ruzan Avetisyan
Publikováno v:
Pharmacoepidemiology and Drug Safety. 21:261-264
Purpose The Food and Drug Administration's (FDA) Mini-Sentinel pilot program initially aims to conduct active surveillance to refine safety signals that emerge for marketed medical products. A key facet of this surveillance is to develop and understa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e35f87b147225d17981a4d9a6ed7d12c
https://doi.org/10.1002/pds.2326
https://doi.org/10.1002/pds.2326
Objectives: The objectives of this research were: (1) to heighten awareness of Gaucher disease (GD), a rare lysosomal storage disorder with highly heterogeneous patterns of organ involvement and disease severity, to clinicians most likely to encounte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f9eae66a861ed64685ccf62a029d199
Publikováno v:
BMC Psychiatry
Background There is a lack of consistency in findings across studies on the prevalence of schizophrenia, and no recent systematic review of the literature exists. The purpose of this study is to provide an updated systematic review of population-base
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::181650bb8a63192e1b86da534e151553
https://doi.org/10.1186/s12888-015-0578-7
https://doi.org/10.1186/s12888-015-0578-7
Autor:
Dana Y. Teltsch, Corey Casper, Thomas M. Habermann, Ming Qi, Angela Dispenzieri, Don Robinson, Philip Rotella, M.W. Reynolds, M.P. Desrosiers
Publikováno v:
British journal of haematology. 168(1)
Summary Multicentric Castleman disease (MCD) is a rare lymphoproliferative disease. Little is known about how patient clinical features and healthcare utilization varies by human immunodeficiency virus (HIV) status and disease subtype. Data of MCD pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fdc150a97e00eba97470122f1873d0f
https://pubmed.ncbi.nlm.nih.gov/25208471
https://pubmed.ncbi.nlm.nih.gov/25208471